Dr. David Antoniuk
CEO & Co-founder
Dr. Antoniuk holds a Ph.D. in Engineering Physics from the University of Alberta and brings 30 years of business development, product marketing and executive management experience. David has extensive experience in technology commercialization and building strategic business relationships. Prior to forming AQM, he was Director of Business Development for TRLabs, Canada’s largest IT consortium; and Director, Nanotechnology where he formulated the strategy for creating a nanotechnology initiative for the Government of Alberta. David has co-founded several technology start-ups. He currently volunteers as the President of the nanoCluster Alberta Association.
Dr. Jonathan Veinot
CTO & Co-founder
Dr. Veinot is a professor at the University of Alberta, Department of Chemistry. He is the co-author on over 175 peer-reviewed papers and been awarded 19 patents. Jonathan is one of the world’s leaders in silicon nanomaterials, focusing on developing non-toxic Group 14 nanomaterials while establishing a fundamental understanding of their unique optical and chemical properties. Dr. Veinot was an invited OECD Expert for the Environmental Impact of Nanomaterials, Berlin 2013. Dr. Veinot is also the Director of the Alberta/Technical University of Munich International Graduate School for Hybrid Functional Materials. He received the prestigious 2017 Award for Excellence in Materials Chemistry from the Canadian Chemical Society as one of “Canada’s shining scientific lights” in the field of silicon nanocrystals and the 2016 Burghausen Chemistry Award, recognized by the chemical industry of Bavaria, Germany for his impressive contributions to the field of silicon nanomaterials.
Dr. Morteza (Mori) Javadi
Director, Scientific Product Development
Dr. Javadi joined Applied Quantum Materials in November 2017. With a PhD in Inorganic and Materials Chemistry from the University of Alberta and a M.Sc. in Nano-Chemistry from the University of Tehran, Mori has a wide background in nanotechnology and materials chemistry. Prior to working at AQM, Mori did his post-doctoral research with Professor Jonathan Veinot at the University of Alberta, working on the synthesis of silicon and germanium semiconductor nanomaterials. Mori is also familiar with nanomaterials in building and construction applications. Before starting his PhD, Mori was working as a Chemist with the Building and Housing Research Centre (BHRC) in Iran.
Dr. Ania Tersakian Sergeenko
Mitacs Elevate Postdoctoral Fellow
Dr. Sergeenko joined Applied Quantum Materials in July 2019. She has a BSc in Chemistry from the University of British Columbia (2014). During her undergraduate studies she worked with Prof. Derek Gates in Main Group phosphorous chemistry, preparing phosphaalkene polymers and cationic initiators for alkene polymerization using standard air sensitive laboratory techniques.
Dr. Sergeenko received her PhD in Inorganic Coordination Chemistry from Simon Fraser University in 2019, where she worked with Prof. Daniel Leznoff. During her PhD, she prepared cyanoplatinate-based coordination polymers with applications as vapo-chromic sensors and negative/zero thermal expansion materials. She is an expert crystallographer, having prepared and determined the crystal structures of 83 new compounds. Dr. Sergeenko is a contributor to a patent for vapo-chromic toxic gas sensors and several peer-reviewed journal articles.
Dr. Matthea Sanderson
Mitacs Elevate Postdoctoral Fellow
Dr. Sanderson joined Applied Quantum Materials in August 2020. She has a B.Sc. in Biology from the University of Saskatchewan (2015) and a Ph.D. in Medical Genetics from the University of Alberta (2020). During her Ph.D., Dr. Sanderson worked in the lab of Dr. Rachel Wevrick, where she studied the genetic and molecular basis of the neurodevelopmental disorders Prader-Willi and Schaaf-Yang syndrome. Her work focused on learning how genetic mutations underlie the phenotypes observed in these conditions. She has a broad knowledge of molecular biology and extensive experience with cellular culture and molecular biology techniques. Dr. Sanderson aims to apply her knowledge of human genetics to the area of molecular diagnostics and testing.
Dr. Nduka Ikpo
Dr. Ikpo, joined Applied Quantum Materials in November 2020. He received an M.Sc. in Instrumental Analytical Science from Robert Gordon University, Aberdeen Scotland and his Ph.D. in Synthetic Chemistry from Memorial University of Newfoundland (MUN) in St John’s, Canada, where his work focused on the development of metal complex catalyst precursors for ring opening polymerization (ROP) of cyclic monomers and copolymerization of carbon dioxide (CO2) with epoxides.
Nduka has strong managerial, technical, and scientific knowledge of materials development. Before joining AQM, Dr. Ikpo worked as Research Scientist in the Veinot Group at the University of Alberta, where he worked on fabrication of metal nanoparticles and development of nanoparticle assay system for the detection and quantification of polyelectrolytes in an aqueous medium.
Nanomaterials Synthetic Chemist
Melissa joined Applied Quantum Materials in November 2020. She has a B.Sc. in Chemistry and Biology from the University of Alberta (2020). During her undergraduate studies she worked with Prof. Frederick G. West investing modification size limitations of 2,5-anhydro-D-mannitol, a fructose analog with a high affinity to GLUT5, a hexose transporter that has increased expression in certain breast cancer cells. At Applied Quantum Materials, Melissa works on nanoparticle synthesis, development of nucleic acid extraction via magnetic beads, development and application of silicon quantum dots.